240 related articles for article (PubMed ID: 24620420)
1. Your business in court and at federal agencies: 2010 - 2011.
Reiss JB; Crowder D; Simons B; Pleskov I; Davis T; Nugent P
Food Drug Law J; 2012; 67(2):243-92, iii. PubMed ID: 24620420
[TBL] [Abstract][Full Text] [Related]
2. Your business in court and at Federal agencies: 2011-2012.
Reiss JB; Crowder D; McCabe B; DeFeo M; Rifin M; Talbot M
Food Drug Law J; 2013; 68(1):1-51, i. PubMed ID: 24640636
[TBL] [Abstract][Full Text] [Related]
3. Your business in court: 2009-2010.
Reiss JB; Hall CR; Wartman GJ
Food Drug Law J; 2011; 66(2):139-81, i. PubMed ID: 24505838
[TBL] [Abstract][Full Text] [Related]
4. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
Basile EM; Tolomeo D; Gluck E
Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
[TBL] [Abstract][Full Text] [Related]
5. Buckman extended: federal preemption of state fraud-on-the-FDA statutes.
Gaddis CA
Food Drug Law J; 2014; 69(1):113-36, iii. PubMed ID: 24772688
[TBL] [Abstract][Full Text] [Related]
6. Preemption of the "fraud on the FDA" exception to Michigan's tort immunity statute for drug manufacturers: reconsidering Garcia and Desiano after Levine.
Murdey J
Food Drug Law J; 2011; 66(1):85-104, ii-iii. PubMed ID: 24505848
[TBL] [Abstract][Full Text] [Related]
7. Marketing nutrition & health-related benefits of food & beverage products: enforcement, litigation & liability issues.
Roller S; Pippins R
Food Drug Law J; 2010; 65(3):447-69, i. PubMed ID: 24479235
[TBL] [Abstract][Full Text] [Related]
8. The impact of Wyeth v. Levine on FDA regulation of prescription drugs.
Ausness RC
Food Drug Law J; 2010; 65(2):247-83, i-ii. PubMed ID: 24475542
[TBL] [Abstract][Full Text] [Related]
9. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
Sayeed SA
Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
[TBL] [Abstract][Full Text] [Related]
10. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST; Pippins RR; Ngai JW
Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
[TBL] [Abstract][Full Text] [Related]
11. Bad medicine: prescription drugs, preemption, and the potential for a no-fault fix.
Smirniotopoulos A
Rev Law Soc Change; 2012; 35(4):793-862. PubMed ID: 22363960
[TBL] [Abstract][Full Text] [Related]
12. Life after Riegel: a fresh look at medical device preemption one year after Riegel v. Medtronic, Inc.
Wartman GJ
Food Drug Law J; 2009; 64(2):291-311. PubMed ID: 19999286
[TBL] [Abstract][Full Text] [Related]
13. The FDA may not regulate tobacco products as "drugs" or as "medical devices".
Merrill RA
Duke Law J; 1998 Apr; 47(6):1071-94. PubMed ID: 10557545
[TBL] [Abstract][Full Text] [Related]
14. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
Alder HC
Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical marketing practices: balancing public health and law enforcement interests; moving beyond regulation-through-litigation.
Zalesky CD
J Health Law; 2006; 39(2):235-64. PubMed ID: 17002233
[TBL] [Abstract][Full Text] [Related]
16. Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in response to court order.
Food and Drug Administration, HHS
Fed Regist; 2003 Oct; 68(201):59714-5. PubMed ID: 14567392
[TBL] [Abstract][Full Text] [Related]
17. Origins of the prohibition against off-label promotion.
Coleman TS
Food Drug Law J; 2014; 69(2):161-236, i. PubMed ID: 25163210
[TBL] [Abstract][Full Text] [Related]
18. Dual regulatory pharmaceutical labeling schemes; the role of the Federal Preemption Doctrine.
Fern FH; Bartell L
Health Matrix; 1987; 5(3):17-23. PubMed ID: 10285381
[TBL] [Abstract][Full Text] [Related]
19. Importing a change in diet: the proposed food safety law of 2010 and the possible impact on importers and international trade.
May SG
Food Drug Law J; 2010; 65(1):1-35, i. PubMed ID: 24475533
[TBL] [Abstract][Full Text] [Related]
20. Is tobacco a drug? Administrative agencies as common law courts.
Sunstein CR
Duke Law J; 1998 Apr; 47(6):1013-69. PubMed ID: 10557544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
